{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:49:09Z","timestamp":1791532149841,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,8]]},"DOI":"10.7759\/cureus.117662","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:53:22Z","timestamp":1791528802000},"source":"Crossref","is-referenced-by-count":0,"title":["Breast Cancer Radiotherapy Plan Metrics: A Principal Component Analysis Using the Mean Absolute Dose Deviation"],"prefix":"10.7759","author":[{"given":"Olena","family":"Gorobets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meymey","family":"San","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Mrissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sopheary","family":"Yoeun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zineb","family":"Dahbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh Dung","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Heymann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam P","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M","family":"Ryckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Vinh-Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvez","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0167-8140(00)00204-8","article-title":"Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link","volume":"55","author":"Van de Steene J","year":"2000","unstructured":"Van de Steene J, Soete G, Storme G. Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link. RadiotherOncol. 2000, 55:263-72. 10.1016\/s0167-8140(00)00204-8","journal-title":"RadiotherOncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby SC","year":"2013","unstructured":"Darby SC, Ewertz M, McGale P, et al.. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013, 368:987-98. 10.1056\/NEJMoa1209825","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.72.0722","article-title":"Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials","volume":"35","author":"Taylor C","year":"2017","unstructured":"Taylor C, Correa C, Duane FK, et al.. Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials. J Clin Oncol. 2017, 35:1641-9. 10.1200\/JCO.2016.72.0722","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s43586-022-00184-w","article-title":"Principal component analysis","volume":"2","author":"Greenacre M","year":"2022","unstructured":"Greenacre M, Groenen PJF, Hastie T, D\u2019Enza AI, Markos A, Tuzhilina E. Principal component analysis. Nature Reviews Methods Primers. 2022, 2:100. 10.1038\/s43586-022-00184-w","journal-title":"Nature Reviews Methods Primers"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.meddos.2019.10.004","article-title":"The mean absolute dose deviation\u2014a common metric for the evaluation of dose-volume histograms in radiation therapy","volume":"45","author":"Vinh-Hung V","year":"2020","unstructured":"Vinh-Hung V, Leduc N, Verellen D, Verschraegen C, Dipasquale G, Nguyen NP. The mean absolute dose deviation\u2014a common metric for the evaluation of dose-volume histograms in radiation therapy. Med Dosim. 2020, 45:186-9. 10.1016\/j.meddos.2019.10.004","journal-title":"Med Dosim"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/1533033820947759","article-title":"Two-level factorial pre-Tomobreast pilot study of tomotherapy and conventional radiotherapy in breast cancer: post hoc utility of a mean absolute dose deviation penalty score","volume":"19","author":"Heymann S","year":"2020","unstructured":"Heymann S, Dipasquale G, Nguyen NP, et al.. Two-level factorial pre-Tomobreast pilot study of tomotherapy and conventional radiotherapy in breast cancer: post hoc utility of a mean absolute dose deviation penalty score. Technol Cancer Res Treat. 2020, 19:10.1177\/1533033820947759","journal-title":"Technol Cancer Res Treat"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-020-01731-8","article-title":"Is prone free breathing better than supine deep inspiration breath-hold for left whole-breast radiotherapy? A\u00a0dosimetric analysis","volume":"197","author":"Wang X","year":"2021","unstructured":"Wang X, Fargier-Bochaton O, Dipasquale G, et al.. Is prone free breathing better than supine deep inspiration breath-hold for left whole-breast radiotherapy? A\u00a0dosimetric analysis. Strahlenther Onkol. 2021, 197:317-31. 10.1007\/s00066-020-01731-8","journal-title":"Strahlenther Onkol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan TJ","year":"2010","unstructured":"Whelan TJ, Pignol JP, Levine MN, et al.. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010, 362:513-20. 10.1056\/NEJMoa0906260","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60348-7","article-title":"The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial","volume":"371","author":"Bentzen SM","year":"2008","unstructured":"Bentzen SM, Agrawal RK, Aird EG, et al.. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008, 371:1098-107. 10.1016\/S0140-6736(08)60348-7","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-7-80","article-title":"Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial","volume":"7","author":"Van Parijs H","year":"2012","unstructured":"Van Parijs H, Miedema G, Vinh-Hung V, et al.. Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial. Radiat Oncol. 2012, 7:80. 10.1186\/1748-717X-7-80","journal-title":"Radiat Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-8850-1","article-title":"Description of environmental variables structures","author":"Thioulouse J","year":"2018","unstructured":"Thioulouse J, Dray S, Dufour A-B, Siberchicot A, Jombart T, Pavoine S. Description of environmental variables structures. Multivariate Analysis of Ecological Data With ade4. Springer, New York (NY); 2018. 77-96. 10.1007\/978-1-4939-8850-1"},{"key":"ref12","unstructured":"R. a language and environment for statistical computing. Version 4.3.2. (2023). (2024). Accessed: February 4, 2024: https:\/\/www.r-project.org\/."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.11284970","article-title":"R program for a principal component analysis using the mean absolute dose deviation (version v7)","author":"Gorobets O","year":"2026","unstructured":"Gorobets O, Vinh-Hung V. R program for a principal component analysis using the mean absolute dose deviation (version v7). Zenodo. 2026, 10.5281\/zenodo.11284970","journal-title":"Zenodo"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.49882","article-title":"Understanding the radiation dose variability in nasopharyngeal cancer: an organs-at-risk approach","volume":"15","author":"Bin Sumaida A","year":"2023","unstructured":"Bin Sumaida A, Shanbhag NM, Balaraj KS, et al.. Understanding the radiation dose variability in nasopharyngeal cancer: an organs-at-risk approach. Cureus. 2023, 15:e49882. 10.7759\/cureus.49882","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26692","article-title":"Comparison of dosimetric parameters and clinical outcomes in inversely planned intensity-modulated radiotherapy (IMRT) and field-in-field forward planned IMRT for the treatment of breast cancer","volume":"14","author":"Azharuddin SK","year":"2022","unstructured":"Azharuddin SK, Kumar P, S N, et al.. Comparison of dosimetric parameters and clinical outcomes in inversely planned intensity-modulated radiotherapy (IMRT) and field-in-field forward planned IMRT for the treatment of breast cancer. Cureus. 2022, 14:e26692. 10.7759\/cureus.26692","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10808","article-title":"Dose-volume predictors of radiation pneumonitis after lung stereotactic body radiation therapy (SBRT): implications for practice and trial design","volume":"12","author":"Moiseenko V","year":"2020","unstructured":"Moiseenko V, Grimm J, Yorke E, et al.. Dose-volume predictors of radiation pneumonitis after lung stereotactic body radiation therapy (SBRT): implications for practice and trial design. Cureus. 2020, 12:e10808. 10.7759\/cureus.10808","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.meddos.2024.05.004","article-title":"Organ at risk dose-volume metrics in a series of hypofractionated breast radiotherapy with integrated boost","volume":"49","author":"Vinh-Hung V","year":"2024","unstructured":"Vinh-Hung V, Benziane-Ouaritini N, Belhomme S, et al.. Organ at risk dose-volume metrics in a series of hypofractionated breast radiotherapy with integrated boost. Med Dosim. 2024, 49:380-7. 10.1016\/j.meddos.2024.05.004","journal-title":"Med Dosim"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.7468","article-title":"Association of breast cancer irradiation with cardiac toxic effects: a narrative review","volume":"7","author":"Meattini I","year":"2021","unstructured":"Meattini I, Poortmans PM, Aznar MC, et al.. Association of breast cancer irradiation with cardiac toxic effects: a narrative review. JAMA Oncol. 2021, 7:924-32. 10.1001\/jamaoncol.2020.7468","journal-title":"JAMA Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2016.10.012","article-title":"Decreased lung perfusion after breast\/chest wall irradiation: quantitative results from a prospective clinical trial","volume":"97","author":"Liss AL","year":"2017","unstructured":"Liss AL, Marsh RB, Kapadia NS, et al.. Decreased lung perfusion after breast\/chest wall irradiation: quantitative results from a prospective clinical trial. Int J Radiat Oncol Biol Phys. 2017, 97:296-302. 10.1016\/j.ijrobp.2016.10.012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2008.11.004","article-title":"Helical tomotherapy planning for left-sided breast cancer patients with positive lymph nodes: comparison to conventional multiport breast technique","volume":"73","author":"Goddu SM","year":"2009","unstructured":"Goddu SM, Chaudhari S, Mamalui-Hunter M, et al.. Helical tomotherapy planning for left-sided breast cancer patients with positive lymph nodes: comparison to conventional multiport breast technique. Int J Radiat Oncol Biol Phys. 2009, 73:1243-51. 10.1016\/j.ijrobp.2008.11.004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/1533034614551873","article-title":"Dosimetric evaluation of different intensity-modulated radiotherapy techniques for breast cancer after conservative surgery","volume":"14","author":"Zhang F","year":"2015","unstructured":"Zhang F, Wang Y, Xu W, et al.. Dosimetric evaluation of different intensity-modulated radiotherapy techniques for breast cancer after conservative surgery. Technol Cancer Res Treat. 2015, 14:515-23. 10.1177\/1533034614551873","journal-title":"Technol Cancer Res Treat"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1211544","article-title":"Lung-heart toxicity in a randomized clinical trial of hypofractionated image guided radiation therapy for breast cancer","volume":"13","author":"Van Parijs H","year":"2023","unstructured":"Van Parijs H, Cecilia-Joseph E, Gorobets O, et al.. Lung-heart toxicity in a randomized clinical trial of hypofractionated image guided radiation therapy for breast cancer. Front Oncol. 2023, 13:1211544. 10.3389\/fonc.2023.1211544","journal-title":"Front Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0335-9","article-title":"Two-level factorial experiments","volume":"16","author":"Smucker B","year":"2019","unstructured":"Smucker B, Krzywinski M, Altman N. Two-level factorial experiments. Nat Methods. 2019, 16:211-2. 10.1038\/s41592-019-0335-9","journal-title":"Nat Methods"},{"key":"ref24","article-title":"An Introduction to Medical Statistics","author":"Bland M","year":"2015","unstructured":"Bland M. An Introduction to Medical Statistics. Oxford University Press, Oxford, United Kingdom; 2015."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/C2017-0-01654-3","article-title":"","author":"Riffenburgh RH","year":"2020","unstructured":"Riffenburgh RH, Gillen DL. Statistics in Medicine. Elsevier Science, London, United Kingdom; 2020. 10.1016\/C2017-0-01654-3"},{"key":"ref26","article-title":"Power Analysis Tutorial for Experimental Design Software","author":"Freeman LJ","year":"2014","unstructured":"Freeman LJ, Johnson TH, Simpson JR. Power Analysis Tutorial for Experimental Design Software. Institute for Defense Analyses, Alexandria (VA); 2014."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1207\/s15327906mbr2603_7","article-title":"How many subjects does it take to do a regression analysis","volume":"26","author":"Green SB","year":"1991","unstructured":"Green SB. How many subjects does it take to do a regression analysis. Multivariate Behav Res. 1991, 26:499-510. 10.1207\/s15327906mbr2603_7","journal-title":"Multivariate Behav Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/sim.7993","article-title":"Minimum sample size for developing a multivariable prediction model: part I\u00a0-\u00a0continuous outcomes","volume":"38","author":"Riley RD","year":"2019","unstructured":"Riley RD, Snell KI, Ensor J, et al.. Minimum sample size for developing a multivariable prediction model: part I\u00a0-\u00a0continuous outcomes. Stat Med. 2019, 38:1262-75. 10.1002\/sim.7993","journal-title":"Stat Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.21037\/tcr.2019.10.36","article-title":"Older breast cancer undertreatment: unconscious bias to undertreat - potential role for the International Geriatric Radiotherapy Group?","volume":"9","author":"Nguyen NP","year":"2020","unstructured":"Nguyen NP, Karlsson U, Oboite E, et al.. Older breast cancer undertreatment: unconscious bias to undertreat - potential role for the International Geriatric Radiotherapy Group?. Transl Cancer Res. 2020, 9:S228-35. 10.21037\/tcr.2019.10.36","journal-title":"Transl Cancer Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.4103\/crst.crst_295_23","article-title":"Bridging the cancer care gap and inequities in radiation treatment in India: a narrative review","volume":"6","author":"Gupta N","year":"2023","unstructured":"Gupta N, Chugh Y, Prinja S. Bridging the cancer care gap and inequities in radiation treatment in India: a narrative review. Cancer Res Stat Treat. 2023, 6:554-61. 10.4103\/crst.crst_295_23","journal-title":"Cancer Res Stat Treat"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/252165-breast-cancer-radiotherapy-plan-metrics-a-principal-component-analysis-using-the-mean-absolute-dose-deviation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:53:23Z","timestamp":1791528803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/252165-breast-cancer-radiotherapy-plan-metrics-a-principal-component-analysis-using-the-mean-absolute-dose-deviation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.117662","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,8]]}}}